Exclusive news, data and analytics for financial market professionals
Learn more about
Refinitiv
Skip to main content
Reuters home
World
Business
Markets
Sustainability
Legal
Breakingviews
Technology
Investigations
More
My View
Register
Company
H Lundbeck A/S
Follow
8 results
Healthcare & Pharmaceuticals
category
Japan's Otsuka Pharma gets FDA approval for Alzheimer's agitation drug
May 11, 2023
article with gallery
Business
category
Lundbeck shares spike after positive mid-term profit guidance
February 7, 2023
World
category
U.S. Parkinson's disease incidence far higher than earlier estimates, study shows
December 15, 2022
Business
category
Teva hires ex-Novartis executive to succeed CEO Schultz
November 21, 2022
Business
category
Factbox: Roche's drug failure extends long list of Alzheimer's trial setbacks
November 14, 2022
Business
category
Lundbeck, Otsuka announce positive phase III results for Alzheimer's agitation drug
June 27, 2022
Future of Health
category
Drugmakers, device companies say sanctions may hinder medical supplies to Russia
March 3, 2022
article with gallery
Markets
category
CSL’s Swiss drug punt looks like a bad trip
December 2, 2021
1 to 8 of 8